Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20,000 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate/advanced hepatocellular carcinoma a multicenter propensity matching analysis.
Xu X, Wang MD, Xu JH, Fan ZQ, Diao YK, Chen Z, Jia HD, Liu FB, Zeng YY, Wang XM, Wu H, Qiu W, Li C, Pawlik TM, Lau WY, Shen F, Lv GY, Yang T. Xu X, et al. Among authors: yang t. Front Immunol. 2024 Jan 8;14:1322233. doi: 10.3389/fimmu.2023.1322233. eCollection 2023. Front Immunol. 2024. PMID: 38268916 Free PMC article.
Grading severity of microscopic vascular invasion was independently associated with recurrence and survival following hepatectomy for solitary hepatocellular carcinoma.
Yao LQ, Li C, Diao YK, Liang L, Jia HD, Tang SC, Zeng YY, Wu H, Wang MD, Gu LH, Pawlik TM, Lau WY, Zhang CW, Shen F, Wang K, Yang T. Yao LQ, et al. Among authors: yang t. Hepatobiliary Surg Nutr. 2024 Feb 1;13(1):16-28. doi: 10.21037/hbsn-22-411. Epub 2023 Mar 6. Hepatobiliary Surg Nutr. 2024. PMID: 38322222 Free PMC article.
Development and validation of nomograms to predict survival and recurrence after hepatectomy for intermediate/advanced (BCLC stage B/C) hepatocellular carcinoma.
Diao YK, Sun L, Wang MD, Han J, Zeng YY, Yao LQ, Sun XD, Li C, Shao GZ, Gu LH, Wu H, Xu JH, Lin KY, Fan ZQ, Lau WY, Pawlik TM, Shen F, Lv GY, Yang T. Diao YK, et al. Among authors: yang t. Surgery. 2024 Jul;176(1):137-147. doi: 10.1016/j.surg.2024.03.028. Epub 2024 May 11. Surgery. 2024. PMID: 38734502
Incidence, risk factors, outcomes, and prediction model of surgical site infection after hepatectomy for hepatocellular carcinoma: A multicenter cohort study.
Shen Y, Hu YL, Xu JH, Zhu S, Cai L, Wu YF, Wu XC, Zeng YY, Gu WM, Zhou YH, Liang YJ, Wang H, Chen TH, Liu DQ, Zhang YM, Wang XM, Wang MD, Wu H, Li C, Diao YK, Gu LH, Yao LQ, Chieh Kow AW, Pawlik TM, Wu F, Wang XL, Shen F, Yang T. Shen Y, et al. Among authors: yang t. Eur J Surg Oncol. 2024 Nov 22;51(2):109486. doi: 10.1016/j.ejso.2024.109486. Online ahead of print. Eur J Surg Oncol. 2024. PMID: 39615293
Clinical features, risk factors, outcomes, and prediction model for intrahepatic and perihepatic abscess following hepatectomy for hepatocellular carcinoma.
Zhu S, Gu LH, Shen Y, Xie GL, Zhuang QX, Zeng YY, Wang XD, Zhou YH, Gu WM, Wang H, Chen TH, Zhang YM, Guo HW, Liang YJ, Wang XM, Zhang WG, Cai L, Li C, Yao LQ, Wang MD, Wu H, Wu F, Zhan PY, Shen F, Chieh Kow AW, Yang T. Zhu S, et al. Among authors: yang t. HPB (Oxford). 2024 Dec 10:S1365-182X(24)02433-X. doi: 10.1016/j.hpb.2024.12.003. Online ahead of print. HPB (Oxford). 2024. PMID: 39719716
Perioperative Changes in Serum Transaminases Levels Predicts Long-Term Survival Following Liver Resection of Hepatocellular Carcinoma.
Lu J, Wang F, Zhang W, Ren Y, Yang T, Ratti F, Marques HP, Silva S, Soubrane O, Lam V, Poultsides GA, Popescu I, Grigorie R, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Lyu Y, Zhang XF, Pawlik TM. Lu J, et al. Among authors: yang t. Ann Surg Oncol. 2024 Dec 27. doi: 10.1245/s10434-024-16705-8. Online ahead of print. Ann Surg Oncol. 2024. PMID: 39730966
20,000 results
You have reached the last available page of results. Please see the User Guide for more information.